The Register-Herald, Beckley, West Virginia

Local News

March 7, 2007

Senate panel kills House prescription drug measure

CHARLESTON — A voice vote Wednesday by a Senate panel sounded the death knell to a House measure intended to lower prescription drug costs in West Virginia and force manufacturers to detail marketing and advertising strategies.

But to some Senate Health and Human Resources Committee panelists, certain provisions smacked of an anti-business flavor, including one that could send drug makers to prison up to 10 years for stopping production of an unprofitable product if viewed as an attempt to fix prices.

In its move, the committee refused to send out HB3164, even though a lead sponsor, Delegate Don Perdue, D-Wayne, offered a compromise with Gov. Joe Manchin earlier in the day.

The bill was an updated model of the affordability and availability act of 2004 and had attracted massive support from a coalition of education, labor and religious leaders across the state.

Manchin had insisted from the get-go that any negotiations by West Virginia to lower drug costs be done by a consortium of eight states, rather than 5 million covered individuals.

Perdue agreed to a consortium of five states, suggesting the House would agree to that.

Even before the panel elected to reject the House measure, Senate Health and Human Resources Chairman Roman Prezioso, D-Marion, wanted to ship it off to the judiciary committee for further review, given a host of penalties for price fixing.

Afterward, two panelists agreed the Senate vote was a proper one.

“I’m as concerned as much as anybody about the cost of health care, and in particular, prescription drugs,” Sen. Jesse Guills, R-Greenbrier, said after the committee vote.

“But this bill doesn’t solve that problem. It was a severe restriction on trade, in my opinion.”

Guills said he would have been more inclined to support Manchin’s proposed strike and insert bill, and was prepared to offer amendments on his own.

Text Only
Local News